CUSIP 74365A309COMPLXQ4 2025
24 filings · latest Mar 4, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 3.65M | $6.56M |
| 2 | Opaleye Management Inc. | 2.48M | $4.46M |
| 3 | Renaissance Technologies LLC | 1.26M | $2.27M |
| 4 | Northern Trust Corp | 865.7K | $1.56M |
| 5 | Geode Capital Management, LLC | 830.1K | $1.49M |
| 6 | State Street Corp | 585.3K | $1.05M |
| 7 | Stratos Wealth Partners, Ltd. | 500.0K | $900.0K |
| 8 | Vanguard Group Inc | 488.6K | $879.4K |
| 9 |
| 4 | Jan 3, 2023 | Nacht Marius | 13G/A | 5.3% | 2.82M | SEC |
| 5 | Jun 9, 2022 | Whitebox Advisors LLC | 13G | 5.7% | 2.82M | SEC |
| 6 | Feb 14, 2022 | Highbridge Capital Management LLC | 13G/A | 5.0% | 2.41M | SEC |
| 7 | Feb 11, 2022 | Highbridge Capital Management LLC | 13G/A | — | — | SEC |
| 8 | Jan 31, 2022 | Nacht Marius | 13G/A | 5.8% | 2.82M | SEC |
| 9 | Jul 30, 2021 | Burrage Capital Management LLC | 13G/A | — | — | SEC |
| 10 | Jun 15, 2021 | Dexcel Pharma Technologies Ltd. | 13G/A | 4.5% | 2.03M | SEC |
See the full Schedule 13D/13G history for Protalix Biotherapeutics Inc.
Unlock full history| 317.6K |
| $571.7K |
| 10 | Jane Street Group, LLC | 289.9K | $521.9K |